Dividends

Here’s why Merck’s 4% dividend yield, low valuation, and 32% upside potential by 2027 could make it an attractive pick for long-term investors.

Here’s why Medtronic’s 3.2% dividend yield, strong 2025 payout coverage, and nearly 28% upside potential make it a compelling long-term opportunity for dividend income-focused investors.

Here’s why CMS Energy (CMS) could be a smart dividend pick right now for its 3.1% yield, 19 years of dividend growth, and 15.8% upside potential based on recent analyst forecasts and earnings strength.

Here’s why Eversource might be worth a closer look. With a 4.75% dividend yield and around 22% upside potential, analysts see a path to steady long-term returns from this undervalued utility.

Here’s why Tyson stock may be an underrated dividend play. With a 3.6% yield and 34% upside potential, analysts see room for long-term total returns.

Here’s why NextEra Energy stock could offer both income and long-term growth. With a 3.1% dividend yield, a 31-year dividend growth streak, and a strong position in clean energy and utilities, analysts believe NEE has the potential to deliver 39% total upside by 2027 as earnings rebound.